Human parvovirus B19 and low hemoglobin levels in pregnant Sudanese women
7
Citation
20
Reference
10
Related Paper
Citation Trend
Keywords:
Seroprevalence
Univariate analysis
Cross-sectional study
A sampling of equids from the state of Oklahoma produced an estimate of seroprevalence of antibody to Sarcocystis neurona to be about 89.2%. This figure represents the highest currently reported regional seroprevalence of antibody to this organism. Regional differences in seroprevalence were found in the western quadrants of the state relative to the eastern quadrants of the state, with a significantly higher seroprevalence in the eastern regions. Thoroughbreds were found to exhibit a statistically significant lower seroprevalence as a breed group when compared with other breeds sampled.
Seroprevalence
Cite
Citations (29)
Abstract Objective : Parvovirus B19 is an important cause of chronic anemia in human immunodeficiency virus (HIV)-positive patients. Extensive seroprevalence studies for parvovirus B19 in HIV-positive individuals have not been carried out in the United States. The authors compared the seroprevalence for parvovirus B19 among patients with asymptomatic HIV infection and healthy blood donors. Methods : The seroprevalence of IgG antibodies to VP-1, a parvovirus B19 structural protein, was determined using an indirect enzyme immunoassay (EIA) and a Western blot assay in 72 HIV-positive adults without prior opportunistic infection or acquired immunodeficiency syndrome (AIDS)-related malignancy and results were compared to those of 134 healthy blood donors. Results : There was a significantly higher seroprevalence for parvovirus 1319 in HIV-positive subjects (57/72, 79%) than in the controls (58/134, 43%) (P Conclusions : These results suggest an increased seropositivity to parvovirus B19 among HIV-positive individuals compared to healthy controls.
Seroprevalence
Cite
Citations (1)
Sera samples (575) were collected from 17 breeds of apparently healthy dogs from different parts of the country and tested for the presence of antibodies against cytotoxin-I antigen ELISA from S. Weltevreden (BM1613) to know the seroprevalence of salmonellosis. The overall seroprevalence was 58.08%. Place-wise the highest seroprevalence was in sera samples collected from Dehradun (92.00%), while breed-wise maximum sera samples of Labrador (81.58%) showed the presence of anti- cytotoxin-I antibodies of salmonella. The difference of seroprevalence of salmonellosis between 2 sexes was nonsignificant and the age group of 7–9 years and above showed the highest serprevalence (63.37%). Our results showed a high seroprevalence of salmonellosis in dogs, which indicates a serious threat to human health.
Seroprevalence
Cite
Citations (2)
Abstract Bovine viral diarrhea (BVD) is a viral disease of cattle with a high economic impact. To estimate the seroprevalence of Bovine viral diarrhea virus (BVDV) infection of cattle on smallholder farms we included 78 smallholder farms in the Belgrade epizootiological area where 318 blood serum samples from cattle were collected, and subsequently tested. The samples were analyzed using a commercially available competitive enzyme immunoassay (ELISA) for the detection of antibodies against BVDV. The obtained results showed an overall seroprevalence of 3.8% whereas the seroprevalence on herd level varied from 0% to 80%. The obtained results showed a relatively low seroprevalence of BVD infection on smallholder farms on the territory of Belgrade city.
Seroprevalence
Pestivirus
Cite
Citations (3)
Seroprevalence of Toxoplasma gondii infection in pigs in 10 regions of Zhejiang Province, China, was obtained by enzyme-linked immunosorbent assay (ELISA). Anti–T. gondii antibodies were found in 53.4% (434/813) of pigs. Results were analyzed by a chi-square (χ2) test. Differences were observed according to farm size, animal age, and sampling regions. Seroprevalences in pigs raised on small farms (71.4%) were significantly higher than that (42.7%) on large farms (P < 0.05), and seroprevalence increased progressively with age. The seroprevalence ranged from 28.1% to 66.0% in different regions, with Jiaxing having the lowest level (28.1%), followed by Hangzhou (36.0%) and Taizhou (42.0%). This is the first study on seroprevalence of T. gondii infection in pigs in Zhejiang Province.
Seroprevalence
Toxoplasmosis
Cite
Citations (30)
Summary Hepatitis E is considered an emerging human viral disease in industrialized countries. Studies from Switzerland report a human seroprevalence of hepatitis E virus ( HEV ) of 2.6–21%, a range lower than in adjacent European countries. The aim of this study was to determine whether HEV seroprevalence in domestic pigs and wild boars is also lower in Switzerland and whether it is increasing and thus indicating that this zoonotic viral infection is emerging. Serum samples collected from 2,001 pigs in 2006 and 2011 and from 303 wild boars from 2008 to 2012 were analysed by ELISA for the presence of HEV ‐specific antibodies. Overall HEV seroprevalence was 58.1% in domestic pigs and 12.5% in wild boars. Prevalence in domestic pigs was significantly higher in 2006 than in 2011. In conclusion, HEV seroprevalence in domestic pigs and wild boars in Switzerland is comparable with the seroprevalence in other countries and not increasing. Therefore, prevalence of HEV in humans must be related to other factors than prevalence in pigs or wild boars.
Seroprevalence
Hepatitis E Virus
Wild boar
Hepatitis E
Prevalence
Cite
Citations (49)
Large outbreaks of hepatitis E virus have been reported in warm climates with poor sanitation although it exists in endemic form in these areas too. This oro-fecally transmitted infection has been described mainly in adults with very little data from children. This study looked at seroprevalence in children resident in a rural district in Ghana with very little pipe-borne water supply. Sera from 803 randomly selected pupils aged 6-18 years were evaluated for anti-HEV. The overall seroprevalence was 4.4% with seroprevalence increasing from 1% in 6-7 year olds to 8.1% in 16-18 year olds. Females had a significantly higher seroprevalence than males. Anti-seroprevalence was also not influenced by the presence of hepatitis B and C virus markers. Anti-HEV seroprevalence was however, far lower than suspected seroprevalence of hepatitis A virus which is also transmitted oro-fecally. The short life of anti-HEV may be responsible for this low seroprevalence.
Seroprevalence
Hepatitis E Virus
Cite
Citations (25)
Seroprevalence studies suggest that the number of PCR-confirmed COVID-19 cases is significantly smaller than the true number of infections. I study logintidual seroprevalence data from 7 sites across the US, from early April 2020 to June 27. I show that not only COVID-19 seroprevalence does not seem to increase over time, there is no clear association between the number of cases reported during a period and the change in seroprevalence during the same time. I conclude that as they are, seroprevalence studies can only be used in the qualitative sense and distinguish between populations with no COVID-19 exposure, to those populations where the virus had already started spreading.
Seroprevalence
2019-20 coronavirus outbreak
Cite
Citations (0)
ABSTRACT Background Few studies have assessed the seroprevalence of antibodies against SARS-CoV-2 among Health Care Workers (HCWs) in Africa. We report findings from a survey among HCWs in three counties in Kenya. Methods We recruited 684 HCWs from Kilifi (rural), Busia (rural) and Nairobi (urban) counties. The serosurvey was conducted between 30 th July 2020 and 4 th December 2020. We tested for IgG antibodies to SARS-CoV-2 spike protein using ELISA. Assay sensitivity and specificity were 93% (95% CI 88-96%) and 99% (95% CI 98-99.5%), respectively. We adjusted prevalence estimates using Bayesian modeling to account for assay performance. Results Crude overall seroprevalence was 19.7% (135/684). After adjustment for assay performance seroprevalence was 20.8% (95% CI 17.5-24.4%). Seroprevalence varied significantly (p<0.001) by site: 43.8% (CI 35.8-52.2%) in Nairobi, 12.6% (CI 8.8-17.1%) in Busia and 11.5% (CI 7.2-17.6%) in Kilifi. In a multivariable model controlling for age, sex and site, professional cadre was not associated with differences in seroprevalence. Conclusion These initial data demonstrate a high seroprevalence of antibodies to SARS-CoV-2 among HCWs in Kenya. There was significant variation in seroprevalence by region, but not by cadre.
Seroprevalence
Cite
Citations (11)